Caris Life Sciences, Inc. (CAI)
18.06
-0.48
(-2.59%)
USD |
NASDAQ |
Nov 20, 10:35
Caris Life Sciences Cash from Operations (Quarterly) : -22.25M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -22.25M |
| June 30, 2026 | 28.48M |
| March 31, 2026 | 32.88M |
| December 31, 2025 | 37.07M |
| September 30, 2025 | 62.42M |
| June 30, 2025 | 7.288M |
| Date | Value |
|---|---|
| March 31, 2025 | -31.34M |
| December 31, 2024 | -38.92M |
| September 30, 2024 | -69.43M |
| June 30, 2024 | -62.93M |
| March 31, 2024 | -73.92M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Natera, Inc. | 43.93M |
| Myriad Genetics, Inc. | -6.50M |
| BioRestorative Therapies, Inc. | -3.808M |
| CareDx, Inc. | 12.72M |
| Exagen, Inc. | -2.575M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -17.47M |
| Cash from Financing (Quarterly) | 14.23M |
| Free Cash Flow | 21.20M |
| Free Cash Flow Per Share (Quarterly) | -0.1346 |
| Free Cash Flow to Equity (Quarterly) | -50.33M |
| Free Cash Flow to Firm (Quarterly) | -31.36M |
| Free Cash Flow Yield | 0.41% |